bmi 25 glp 1 Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans: Cell Reports Medicine Qualifying for GLP-1 Weight Loss:

The present study demonstrated the neuroprotective effects of Acetyl-L- carnitine (ALC) alone or in combination with caffeic acid phenethyl ester (CAPE) on lipopolysaccharide (LPS) induced neuro-inflammation, depression, and anxiety-like behavior

From the approval of Orlistat (Xenical) in 1999, which focused on reducing dietary fat absorption, to the emergence of highly effective incretin-based therapies such as liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound), we have witnessed a fundamental shift in how obesity is understood and treated

40 The Karuna acquisition is expected to close in the first half of 2024, while Bristol Myers prepares to support the launch of KarXT

Impact of the components of metabolic syndrome on oxidative stress and enzymatic antioxidant activity in essential hypertension

One of the well-known senolytic drugs, Navitoclax, also holds the potential for use in One-Two Punch therapy [138]